Successful use of early, repeat fecal microbiota transplantation for initial treatment of severe, refractory Clostridioides difficile colitis

Am J Health Syst Pharm. 2021 Jul 22;78(15):1374-1381. doi: 10.1093/ajhp/zxab161.

Abstract

Purpose: There is a paucity of literature surrounding the use of early fecal microbiota transplantation (FMT) for patients presenting with an initial episode of severe, refractory Clostridioides difficile infection (CDI). Information on optimal antibiotic dosing and therapy duration surrounding FMT during an acute, initial episode of CDI is also limited. Described here is a case of successful treatment of CDI after 4 FMTs during an acute, initial episode of severe, refractory Clostridioides difficile colitis.

Summary: A 69-year-old community-dwelling, Caucasian male presented after 48 hours of vomiting and diarrhea. A stool sample was collected and resulted positive for Clostridioides difficile by both polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA). The patient was treated with several days of oral and rectal vancomycin therapy in addition to intravenous metronidazole, but those treatments failed. His clinical and nutrition status deteriorated over the course of several days until salvage therapy was ordered, with administration of 1 inpatient nasogastric FMT and 1 inpatient colonoscopic FMT followed by outpatient colonoscopic FMTs on 2 consecutive days within 2 weeks of hospital discharge.

Conclusion: This case suggests a role for early, repeat FMT during an initial presentation of a severe Clostridioides difficile colitis episode refractory to pharmacologic antimicrobial therapy. It also adds to emerging literature regarding the timing of antibiotic cessation surrounding FMT.

Keywords: Cdiff; Clostridioides difficile; Clostridium difficile; FMT; fecal microbiota transplant; fecal microbiota transplantation.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Clostridioides
  • Clostridioides difficile*
  • Clostridium Infections* / diagnosis
  • Clostridium Infections* / therapy
  • Colitis* / therapy
  • Fecal Microbiota Transplantation
  • Humans
  • Male
  • Recurrence
  • Treatment Outcome